Literature DB >> 10851394

Myositis during long-term interferon-alpha treatment.

G J Hengstman1, O J Vogels, H J ter Laak, T de Witte, B G van Engelen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10851394     DOI： 10.1212/wnl.54.11.2186

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  3 in total

Review 1.  Toxic myopathies.

Authors:  Mamatha Pasnoor; Richard J Barohn; Mazen M Dimachkie
Journal:  Neurol Clin       Date:  2014-08       Impact factor: 3.806

2.  Suppression of soluble T cell-associated proteins by an anti-interferon-α monoclonal antibody in adult patients with dermatomyositis or polymyositis.

Authors:  Xiang Guo; Brandon W Higgs; Marlon Rebelatto; Wei Zhu; Warren Greth; Yihong Yao; Lorin K Roskos; Wendy I White
Journal:  Rheumatology (Oxford)       Date:  2013-12-19       Impact factor: 7.580

Review 3.  Dermatomyositis as a complication of interferon-α therapy: a case report and review of the literature.

Authors:  Hideyuki Shiba; Tohru Takeuchi; Kentaro Isoda; Yasuhito Kokunai; Yumiko Wada; Shigeki Makino; Toshiaki Hanafusa
Journal:  Rheumatol Int       Date:  2014-03-18       Impact factor: 2.631
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.